Incidence proportion and prognosis of leptomeningeal disease among patients with breast versus non-breast primaries.

Nayan LambaDaniel N CagneyPaul J CatalanoHesham ElhalawaniDaphne A Haas-KoganPatrick Y WenNikhil WagleNancy U LinAyal A AizerShyam Tanguturi

Published in: Neuro-oncology (2022)

Patients with breast cancer and LMD may represent an ideal population for clinical trials given the higher incidence and potentially more favorable prognosis seen in this population.

Keyphrases

clinical trial
risk factors
small cell lung cancer
randomized controlled trial
open label
phase ii
study protocol